$CLVS Company News Six stocks to watch 12:47 p.m. Aug.

New Post Public Reply Private Reply Replies (0) Message Board

Jan 14, 2015 at 10:26 AM

$CLVS Company News

Six stocks to watch 12:47 p.m. Aug. 27, 2014 - The Trading Deck
Clovis falls 22% over two days on disappointing cancer drug trials 10:56 a.m. June 3, 2014 - Russ Britt
Clovis shares jump as company prepares to give cancer drug results 1:31 p.m. May 15, 2014 - Russ Britt
Biotechs, bonds and more from the 'tempest in a microsecond' 7:32 a.m. April 2, 2014 - Shawn Langlois
Charting a firmly-grounded, bull-market trend 1:01 p.m. March 4, 2014 - Michael Ashbaugh
Charting a firmly-grounded, bull-market trend 12:41 p.m. March 4, 2014 - Michael Ashbaugh
Losses widen, but investors heartened by Clovis drug results 11:01 a.m. Feb. 28, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Ascena Retail shares rally after hours 4:50 p.m. Sept. 24, 2013 - Wallace Witkowski
Trade what you see, not what you believe 12:30 p.m. Aug. 29, 2013 - The Trading Deck
There are two ways to play earnings 11:00 a.m. Aug. 1, 2013 - The Trading Deck
5 stocks that hedge funds are buying 11:35 a.m. June 24, 2013 - Insider Monkey
Clovis Oncology unveils $170 mln share offering 7:09 a.m. June 10, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:53 p.m. Nov. 12, 2012 - Wallace Witkowski
Clavis plunges after negative cancer drug trial 8:40 a.m. Nov. 12, 2012 - MarketWatch.com
IPO scorecard: Update on selected offering 1:18 p.m. June 8, 2012 - Dow Jones
Stocks to watch Wednesday: DDi, SanDisk, Mitcham 7:26 a.m. April 4, 2012 - MarketWatch
InvenSense closes up 19% after IPO; Clovis down 4:45 p.m. Nov. 16, 2011 - MarketWatch.com
Biopharma Clovis trades higher post-IPO 12:18 p.m. Nov. 16, 2011 - MarketWatch.com

Clovis Oncology, Inc. (CLVS) in Focus: Stock Jumps 5.9% - Tale of the Tape 9:18 a.m. Today - Zacks.com
Hottest Healthcare Stocks Now – ARIA ACHN KERX CLVS 12:15 p.m. Jan. 7, 2015 - InvestorPlace.com
Hottest Healthcare Stocks Now – SGMO ANAC CMN CLVS 6:00 a.m. Dec. 31, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ISIS NBIX CLDX EXAS 6:15 a.m. Dec. 26, 2014 - InvestorPlace.com
FDA Approves AstraZeneca Ovarian Cancer Drug 5:12 p.m. Dec. 19, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst Blog 4:48 p.m. Dec. 19, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – PODD INCY ACAD ALNY 12:15 p.m. Dec. 17, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ZLTQ PBYI CLVS ACHC 12:30 p.m. Dec. 11, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ISRG VRTX CLVS VAR 1:45 p.m. Dec. 8, 2014 - InvestorPlace.com
Vargatef cleared in Europe for lung cancer 9:23 a.m. Nov. 28, 2014 - Seeking Alpha
CO-1686 Data Confirmed Efficacy, Take Advantage Of Weakness In Clovis Oncology Shares Ahead Of Rucaparib Outcomes Data 11:41 a.m. Nov. 19, 2014 - Seeking Alpha
Clovis Lung Cancer Update Swings Momentum to Rival, Slightly 9:38 a.m. Nov. 19, 2014 - TheStreet.com
Clovis off premarket after report on CO-1686 9:21 a.m. Nov. 19, 2014 - Seeking Alpha
Clovis teams up with Glaxo on combo cancer therapy 7:20 a.m. Nov. 18, 2014 - Seeking Alpha
Clovis Oncology Enters Into Oncology Clinical Trial Collaboration With GlaxoSmithKline 4:00 p.m. Nov. 17, 2014 - benzinga.com
Clovis Oncology's (CLVS) CEO Presents at Credit Suisse 2014 Healthcare Conference (Transcript) 9:10 p.m. Nov. 11, 2014 - Seeking Alpha
10-Q: CLOVIS ONCOLOGY, INC. 1:13 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS 7:33 a.m. Nov. 7, 2014 - benzinga.com
Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q3 2014 Results - Earnings Call Transcript 9:40 p.m. Nov. 6, 2014 - Seeking Alpha
Notable earnings after Thursday’s close 5:35 p.m. Nov. 5, 2014 - Seeking Alpha

Clovis Oncology to Present at the 33rd Annual J.P. Morgan Healthcare Conference 6:30 p.m. Jan. 5, 2015 - BusinessWire - BZX
Foundation Medicine’s Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis Oncology’s PARP inhibitor, Rucaparib 6:05 p.m. Nov. 19, 2014 - BusinessWire - BZX
Clovis Oncology Enters into Oncology Clinical Trial Collaboration with GlaxoSmithKline 5:00 p.m. Nov. 17, 2014 - BusinessWire - BZX
Clovis Oncology Announces First Patient Enrolled in TIGER-1 Study 5:28 p.m. Nov. 12, 2014 - BusinessWire - BZX
Clovis Oncology Announces Third Quarter 2014 Operating Results 4:05 p.m. Nov. 6, 2014 - BusinessWire - BZX
Clovis Oncology to Present at the 2014 Credit Suisse Healthcare Conference 4:11 p.m. Nov. 4, 2014 - BusinessWire - BZX
Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in Squamous Non-small Cell Lung Cancer 3:52 p.m. Oct. 23, 2014 - BusinessWire - BZX
Clovis Oncology to Announce Third Quarter 2014 Financial Results and Host Webcast Conference Call on November 6 8:03 a.m. Oct. 22, 2014 - BusinessWire - BZX
Critical Alerts For Yahoo!, Clovis Oncology, Sears Holdings, PetSmart and Endo Health Solutions Released By InvestorsObserver 8:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in FGF-aberrant Advanced Breast Cancer 3:01 p.m. Sept. 10, 2014 - BusinessWire - BZX
Clovis Oncology Announces Exercise in Full by Initial Purchasers of Their Option to Purchase an Additional $37.5 Million Aggregate Principal Amount of the Company’s 2.50% Convertible Senior Notes Due 2021 7:02 a.m. Sept. 9, 2014 - BusinessWire - BZX
Clovis Oncology to Present at the 2014 Morgan Stanley Global Healthcare Conference 5:01 a.m. Sept. 8, 2014 - BusinessWire - BZX
Clovis Oncology Announces Pricing of $250 Million of Convertible Senior Notes 7:22 p.m. Sept. 3, 2014 - BusinessWire - BZX
Clovis Oncology to Offer $200 Million of Convertible Senior Notes 3:03 p.m. Sept. 2, 2014 - BusinessWire - BZX
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 12:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
Clovis Oncology Announces Second Quarter 2014 Operating Results 3:02 p.m. Aug. 7, 2014 - BusinessWire - BZX
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 7:50 a.m. July 30, 2014 - PR Newswire - PRF
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 7:10 a.m. July 17, 2014 - PR Newswire - PRF
Patient Enrollments, Board Appointments, Acquisitions, and Technical Updates - Analyst Notes on Questcor, Synta, Clovis, Alnylam and Intrexon 4:10 a.m. July 8, 2014 - PR Newswire - PRF
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 6:50 a.m. June 27, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

eGlint's Rapid Tech Revolutionizes Proteomics with Win

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Plata Hits $1 Billion ARR in Record Digital Bank Growth

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Standex's New Financial Lead: Stoddard Takes Helm

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Ama La Vida's New Coaching: More Than a Financial Plan

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

TomoIQ Unveils Money Finder at Money20/20 Event

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

U.S. Millionaire Surge: Market Waves or Mirage?

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

OppFi Readies Q3 Earnings; Investors Eye Financials

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Alaska LNG Project Boosted by Strategic Positioning

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Workday Hits High Note in 2026 Gartner Magic Quadrant

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Roof Inspections: Richmond's Key to Home Longevity

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...